日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Applying Safety Science to Sepsis Case Review

将安全科学应用于脓毒症病例审查

Liberati, Elisa Giulia; Martin, Graham P; Lamé, Guillaume; Waring, Justin; Tarrant, Carolyn; Willars, Janet; Dixon-Woods, Mary; Lucey, Kate; Maciorowski, Kim; O’Connell, Megan; Kass, Carolyn; DeNicolo, Kimberly; Stephen, Rebecca J

Boost and Increased Antibody Breadth Following a Second Dose of PARVAX for SARS-CoV-2 in Mice and Nonhuman Primates

在小鼠和非人类灵长类动物中,第二次接种 PARVAX 疫苗后,其针对 SARS-CoV-2 的抗体增强作用和抗体宽度增加

Urja Bhatt, Cecile Herate, Reynette Estelien, Francis Relouzat, Nathalie Dereuddre-Bosquet, Dawid Maciorowski, Cheikh Diop, Emma Couto, Jillian Staiti, Mariangela Cavarelli, Laëtitia Bossevot, Quentin Sconosciuti, Page Bouchard, Roger Le Grand, Luk H Vandenberghe, Nerea Zabaleta

Immunogenicity of an AAV-Based COVID-19 Vaccine in Murine Models of Obesity and Aging

基于 AAV 的 COVID-19 疫苗在肥胖和衰老小鼠模型中的免疫原性

Dawid Maciorowski, Cheikh Diop, Urja Bhatt, Reynette Estelien, Dan Li, Ruchi Chauhan, Luk H Vandenberghe, Nerea Zabaleta

Iron dysregulation in COVID-19 and reciprocal evolution of SARS-CoV-2: Natura nihil frustra facit

COVID-19 中的铁代谢紊乱与 SARS-CoV-2 的相互演化:Natura nihil frustra facit

Gupta, Yash; Maciorowski, Dawid; Medernach, Brian; Becker, Daniel P; Durvasula, Ravi; Libertin, Claudia R; Kempaiah, Prakasha

An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates

一种基于腺相关病毒(AAV)的、室温稳定的单剂量新冠疫苗在非人灵长类动物中可提供持久的免疫原性和保护作用。

Nerea Zabaleta ,Wenlong Dai ,Urja Bhatt ,Cécile Hérate ,Pauline Maisonnasse ,Jessica A Chichester ,Julio Sanmiguel ,Reynette Estelien ,Kristofer T Michalson ,Cheikh Diop ,Dawid Maciorowski ,Nathalie Dereuddre-Bosquet ,Mariangela Cavarelli ,Anne-Sophie Gallouët ,Thibaut Naninck ,Nidhal Kahlaoui ,Julien Lemaitre ,Wenbin Qi ,Elissa Hudspeth ,Allison Cucalon ,Cecilia D Dyer ,M Betina Pampena ,James J Knox ,Regina C LaRocque ,Richelle C Charles ,Dan Li ,Maya Kim ,Abigail Sheridan ,Nadia Storm ,Rebecca I Johnson ,Jared Feldman ,Blake M Hauser ,Vanessa Contreras ,Romain Marlin ,Raphaël Ho Tsong Fang ,Catherine Chapon ,Sylvie van der Werf ,Eric Zinn ,Aisling Ryan ,Dione T Kobayashi ,Ruchi Chauhan ,Marion McGlynn ,Edward T Ryan ,Aaron G Schmidt ,Brian Price ,Anna Honko ,Anthony Griffiths ,Sam Yaghmour ,Robert Hodge ,Michael R Betts ,Mason W Freeman ,James M Wilson ,Roger Le Grand ,Luk H Vandenberghe

Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy

肝素:鉴于其体外纳摩尔级功效,一种简便的用途再利用方法可用于预防SARS-CoV-2传播。

Yash Gupta ,Dawid Maciorowski ,Samantha E Zak ,Chandrashekhar V Kulkarni ,Andrew S Herbert ,Ravi Durvasula ,Jawed Fareed ,John M Dye ,Prakasha Kempaiah

Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays

双吲哚马来酰亚胺 IX:一种针对病毒主蛋白酶 3CLpro 的新型抗 SARS-CoV2 药物,通过虚拟筛选流程和体外验证试验证明

Yash Gupta, Dawid Maciorowski, Samantha E Zak, Krysten A Jones, Rahul S Kathayat, Saara-Anne Azizi, Raman Mathur, Catherine M Pearce, David J Ilc, Hamza Husein, Andrew S Herbert, Ajay Bharti, Brijesh Rathi, Ravi Durvasula, Daniel P Becker, Bryan C Dickinson, John M Dye, Prakasha Kempaiah

Environmental factors and their role in the transmission of SARS-CoV-2

环境因素及其在SARS-CoV-2传播中的作用

Maciorowski, Dawid; Sharma, Divakar; Kunamneni, Adinarayana

Therapeutic and Vaccine Options for COVID-19: Status after Six Months of the Disease Outbreak

新冠肺炎的治疗和疫苗选择:疫情爆发六个月后的现状

Maciorowski, Dawid; Ogaugwu, Christian; Durvasula, Subba Rao; Durvasula, Ravi; Kunamneni, Adinarayana

Testing-Related and Geo-Demographic Indicators Strongly Predict COVID-19 Deaths in the United States during March of 2020

检测相关指标和地理人口统计指标能够有效预测2020年3月美国新冠肺炎死亡人数

James, B Hittner; Folorunso, O Fasina; Almira, L Hoogesteijn; Renata, Piccinini; Dawid, Maciorowski; Prakasha, Kempaiah; Stephen, D Smith; Ariel, L Rivas